% alzhub.org library filter % Source: https://alzhub.org/research?category=treatments&year=2000 % 17 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{mckeith2000-11145488, author = {McKeith, I. and Del Ser, T. and Spano, P. and Emre, M. and Wesnes, K. and Anand, R. and Cicin-Sain, A. and Ferrara, R. and others}, title = {{Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study}}, journal = {Lancet (London, England)}, year = {2000}, doi = {10.1016/s0140-6736(00)03399-7}, pmid = {11145488}, url = {https://doi.org/10.1016/s0140-6736(00)03399-7} } @article{raskind2000-10881250, author = {Raskind, M. A. and Peskind, E. R. and Wessel, T. and Yuan, W.}, title = {{Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group}}, journal = {Neurology}, year = {2000}, doi = {10.1212/wnl.54.12.2261}, pmid = {10881250}, url = {https://doi.org/10.1212/wnl.54.12.2261} } @article{mulnard2000-10697060, author = {Mulnard, R. A. and Cotman, C. W. and Kawas, C. and van Dyck, C. H. and Sano, M. and Doody, R. and Koss, E. and Pfeiffer, E. and others}, title = {{Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study}}, journal = {JAMA}, year = {2000}, doi = {10.1001/jama.283.8.1007}, pmid = {10697060}, url = {https://doi.org/10.1001/jama.283.8.1007} } @article{street2000-11015815, author = {Street, J. S. and Clark, W. S. and Gannon, K. S. and Cummings, J. L. and Bymaster, F. P. and Tamura, R. N. and Mitan, S. J. and Kadam, D. L. and others}, title = {{Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group}}, journal = {Archives of general psychiatry}, year = {2000}, doi = {10.1001/archpsyc.57.10.968}, pmid = {11015815}, url = {https://doi.org/10.1001/archpsyc.57.10.968} } @article{rogers2000-10793322, author = {Rogers, S. L. and Doody, R. S. and Pratt, R. D. and Ieni, JR.}, title = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study}}, journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology}, year = {2000}, doi = {10.1016/s0924-977x(00)00067-5}, pmid = {10793322}, url = {https://doi.org/10.1016/s0924-977x(00)00067-5} } @article{higgins2000-11034695, author = {Higgins, J. P. and Flicker, L.}, title = {{Lecithin for dementia and cognitive impairment}}, journal = {The Cochrane database of systematic reviews}, year = {2000}, doi = {10.1002/14651858.cd001015}, pmid = {11034695}, url = {https://doi.org/10.1002/14651858.cd001015} } @article{wilcock2000-11110737, author = {Wilcock, G. K. and Lilienfeld, S. and Gaens, E.}, title = {{Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group}}, journal = {BMJ (Clinical research ed.)}, year = {2000}, doi = {10.1136/bmj.321.7274.1445}, pmid = {11110737}, url = {https://doi.org/10.1136/bmj.321.7274.1445} } @article{farlow2000-11096224, author = {Farlow, M. and Anand, R. and Messina, J. and Hartman, R. and Veach, J.}, title = {{A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease}}, journal = {European neurology}, year = {2000}, doi = {10.1159/000008243}, pmid = {11096224}, url = {https://doi.org/10.1159/000008243} } @article{homma2000-11044775, author = {Homma, A. and Takeda, M. and Imai, Y. and Udaka, F. and Hasegawa, K. and Kameyama, M. and Nishimura, T.}, title = {{Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group}}, journal = {Dementia and geriatric cognitive disorders}, year = {2000}, doi = {10.1159/000017259}, pmid = {11044775}, url = {https://doi.org/10.1159/000017259} } @article{emeriau2000-10945510, author = {Emeriau, J. P. and Lehert, P. and Mosnier, M.}, title = {{Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial}}, journal = {Clinical therapeutics}, year = {2000}, doi = {10.1016/s0149-2918(00)80056-9}, pmid = {10945510}, url = {https://doi.org/10.1016/s0149-2918(00)80056-9} } @article{lopezarrieta2000-10796667, author = {López-Arrieta, J. M. and Rodríguez, J. L. and Sanz, F.}, title = {{Nicotine for Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2000}, doi = {10.1002/14651858.cd001749}, pmid = {10796667}, url = {https://doi.org/10.1002/14651858.cd001749} } @article{vandyck2000-10665618, author = {van Dyck, C. H. and Newhouse, P. and Falk, W. E. and Mattes, J. A.}, title = {{Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group}}, journal = {Archives of general psychiatry}, year = {2000}, doi = {10.1001/archpsyc.57.2.157}, pmid = {10665618}, url = {https://doi.org/10.1001/archpsyc.57.2.157} } @article{alvarez2000-11196347, author = {Alvarez, X. A. and Pichel, V. and Pérez, P. and Laredo, M. and Corzo, D. and Zas, R. and Fernández-Novoa, L. and Sempere, J. M. and others}, title = {{Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics}}, journal = {Methods and findings in experimental and clinical pharmacology}, year = {2000}, doi = {10.1358/mf.2000.22.7.802270}, pmid = {11196347}, url = {https://doi.org/10.1358/mf.2000.22.7.802270} } @article{jann2000-10641971, author = {Jann, M W}, title = {{Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease}}, journal = {Pharmacotherapy}, year = {2000}, doi = {10.1592/phco.20.1.1.34664}, pmid = {10641971}, url = {https://doi.org/10.1592/phco.20.1.1.34664} } @article{scott2000-11129124, author = {Scott, L. J. and Goa, K. L.}, title = {{Galantamine: a review of its use in Alzheimer's disease}}, journal = {Drugs}, year = {2000}, doi = {10.2165/00003495-200060050-00008}, pmid = {11129124}, url = {https://doi.org/10.2165/00003495-200060050-00008} } @article{nath2000-10665489, author = {Nath, A. and Haughey, N. J. and Jones, M. and Anderson, C. and Bell, J. E. and Geiger, J. D.}, title = {{Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine}}, journal = {Annals of neurology}, year = {2000}, doi = {10.1002/1531-8249(200002)47:2<186::aid-ana8>3.0.co;2-3}, pmid = {10665489}, url = {https://doi.org/10.1002/1531-8249(200002)47:2<186::aid-ana8>3.0.co;2-3} } @article{sugimoto2000-10637367, author = {Sugimoto, H. and Yamanishi, Y. and Iimura, Y. and Kawakami, Y.}, title = {{Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors}}, journal = {Current medicinal chemistry}, year = {2000}, doi = {10.2174/0929867003375191}, pmid = {10637367}, url = {https://doi.org/10.2174/0929867003375191} }